← FDA Drug Approvals (Drugs@FDA)

QUVIVIQ

NDA · New Drug Application · Sponsor: IDORSIA · Approved 2022-01-07

Drug application

FDA Application #

NDA214985

Application type

New Drug Application

Brand name

QUVIVIQ

Generic name

DARIDOREXANT

Active ingredients

DARIDOREXANT HYDROCHLORIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

IDORSIA

Manufacturer

Idorsia Pharmaceuticals Ltd

First approval

2022-01-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown